Trials / Unknown
UnknownNCT02949466
Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis
Additional Therapeutic Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis: A Double Blind, Randomized-controlled Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Taipei Medical University · Academic / Other
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Using a double-blind, randomized controlled design to investigate the additional therapeutic effects of 3 times of combined triamcinolone and hyaluronic acid injections to 3 times of hyaluronic acid injections to patients with knee osteoarthritis.
Detailed description
A total of 56 patients will be enrolled and randomized into two groups, including 3 times of triamcinolone combined hyaluronic acid injections group and 3 times of hyaluronic acid injections group. The triamcinolone combined hyaluronic acid injections group will receive 3 times of triamcinolone combined hyaluronic acid injection per week in three weeks; the hyaluronic acid group will receive hyaluronic acid injection in three weeks. Physical activities and functional performance will be evaluated at before injection, at after one week, one month, three months, and six months of completion of 3 times of injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone | compare the additional therapeutic effects of triamcinolone combined with hyaluronic acid injections to hyaluronic acid injections only to patients with knee osteoarthritis |
| DEVICE | Hyaluronic acid | compare the additional therapeutic effects of triamcinolone combined with hyaluronic acid injections to hyaluronic acid injections only to patients with knee osteoarthritis |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-10-31
- Last updated
- 2016-11-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02949466. Inclusion in this directory is not an endorsement.